Drug Development Summit: Good News From the Pipeline

  • by: |
  • 01/23/2007
I was both an attendee and speaker at the MedAdNews Drug Development Summit.

Two important takeaway points. Make that three. Ok four.

1. Companies are refilling their pipelines with new drugs that will hit new targets for unmet medical needs in areas like Alzheimer's, cancer, schizophrenia, Parkinson's, respiratory infections and stroke.

2. Companies are doing a better job of weeding out medicines that won't work or would "fail" because of toxicity issues earlier than ever. Drug development is becoming more predictive.

3. Many of the Critical Path recommendations are being adopted. Adaptive trial designs, bio-imaging, exploratory INDs are all being used.

4. Companies are interested in doing more collaborative work to identify biomarkers, both efficacy and safety. Creating the framework for doing so is difficult.

The takeaway: this is an industry furiously seeking to change. It probably should be more transparent and collaborative and find a better way to market its medicines but that will happen too.

The question is, why do some many people still believe that drug companies are sitting on cures for diseases so they can make money? I can't tell you how many otherwise intelligent people have actually asked me if this is true.... Another reason that biotech and drug companies need to tell the public what they do.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog